I. - Basic information

I.1 - Surname

Lubos

I.2 - Name

Drgona

I.3 - Degrees

Associate professor, MD, PhD, MHA

I.4 - Year of birth

1967

I.5 - Name of the workplace

/Comenius University in Bratislava, Faculty of Medicine, Department of Oncohematology

I.6 - Address of the workplace

Klenova 1, 83310 Bratislava

I.7 - Position

Head of Department

I.8 - E-mail address

lubos.drgona@nou.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/5356

I.10 - Name of the study field in which a person works at the university

Oncology

I.11 - ORCID iD

0000-0002-5089-3201

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

1991

II.c - Study field and programme

General Medicine

II.3 - Third degree of higher education

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

1997

II.c - Study field and programme

Clinical Oncology

II.4 - Associate professor

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

2014

II.c - Study field and programme

Oncology

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
fellow	Interná klinika NOU / National Cancer Institute	1991-2027
fellow	II.onkologická klinika LFUK a NOU, /Comenius University in Bratislava, Faculty of Medicine	2007-2014
Head of Department	Comenius University in Bratislava, Faculty of Medicine	2014 - ongoing

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
Board Certification from Clinical Oncology	Comenius University	1997
Fellow of European Confederation of Medical Mycology	European Confederation of Medical Mycology	2019
Masterof Health Administration	St. Elisabeth University and University of Scranton	2016
GCP Certificate	The Global Health Network	2024

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Spoločensky závažné malignity	General Medicine	I.+II.	General Medicine
Oncohematology	General Medicine	I.+II.	General Medicine
Clinical Oncology	Clinical Oncology	III.	General Medicine

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.4.2 - Number of defended theses

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

384

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

3085

VI.1.b - Over the last six years

1600

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.5 - Number of invited lectures at the international, national level

VI.1.a - Overall

VI.1.b - Over the last six years

VI.2 - The most significant research/artistic/other outputs

Kern, Winfried V. - Marchetti, Oscar - Drgoňa, Ľuboš - Akan, Hamdi - Aoun, Mickel - Akova, Murat - deBock, Robrecht - Paesmans, Marianne - Viscoli, Claudio - Calandra, Thierry: Oral antibiotics for fever in low-risk neutropenicpatients with cancer: A double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy - EORTC Infectious Diseases Group Trial XV

Journal of clinical oncology - Vol. 31, No. 9 (2013), s. 1149-1156.

IF (JCR) 2013=17,960

Mego, Michal - Chovanec, Jozef - Vochynová - Andrezalová, Iveta - Konkolovský, Peter - Mikulová, Milada - Rečková, Mária - Novotná, Věra(5%) - Bystrický, Branislav - Beniak, Juraj - Medvecová, Lenka- Lagin, Adela - Světlovská, Daniela - Špánik, Stanislav - Zajac, Vladimír - Mardiak, Jozef - Drgoňa, Ľuboš.Prevention of irinotecan induceddiarrhea by probiotics: A randomized double blind, placebo controlled pilot study

Complementary Therapies in Medicine. - Vol. 23, No. 3 (2015), s. 356-362. - ISSN 0965-2299

IF (JCR) 2015=1,935

Drgoňa, Ľuboš - Gudiol, Carlota - Lanini, Simone - Salzberger, Bernd - Ippolito, Giuseppe - Mikulska, Malgorzata : ESCMID Study Group for Infections in Compromised Hosts(ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

Clinical Microbiology and Infection. - 24, č Supplement 2 (2018), s. S83-S94.

IF (JCR) 2018=6,425

Mikulska, Malgorzata - Cesaro, Simone - de Lavallade, Hugues - Di Blasi, Roberta - Einarsdottir, Sigrun - Drgoňa, Ľuboš: Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Lancet Infectious Diseases. -19, 6 (2019), e188-e189.

IF (JCR) 2019=24,446

Čierniková, Soňa - Kašperová, Barbora - Drgoňa, Ľuboš - Smolková, Božena - Števurková, Viola - Mego, Michal: Targeting the gut microbiome: Anemerging trend in hematopoietic stem cell transplantation

Blood Reviews. - 48 (2021), 1-14

IF (JCR) 2020=8,250

VI.3 - The most significant research/artistic/other outputs over the last six years

Hoenigl, Martin, Salmanton-García, Jon, Egger, Matthias , Gangneux Jean-Pierre, Bicanic, Drgoňa, Ľuboš.

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

Lancet Infect Dis. 2023.(Q1, IF:56,3)

Čierniková, Soňa, Ševčíková, Aneta, Drgoňa, Ľuboš, Mego, Michal:

Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.

Biochimica et biophysica acta. Reviews on cancer. 2023. (Q1, IF:11,2)

Maertens, Johan, Lodewyck, Tom, Donnelly, Peter J., Chantepie, Silvain, Robin, Christine, Drgoňa, Ľuboš.

Empiric vs preemptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for research and treatment of Cancer.

Clin Infect Dis. 2023. (Q1,IF:11,8)

van Doesum, Jaap A, Salmanton-García, Jon, Marchesi, Francesco, Di Blasi, Roberta, Flaces-Romero, Iker, Drgoňa Ľuboš.

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-

directed CAR T-cell therapy: an EPICOVIDEHA survey .

Blood Adv. 2023. (Q1, IF:7,6)

Busca, Alessandro, Salmanton-García, Jon , Corradini, Paolo Marchesi, Francesco Cabirta, Alba, Drgoňa, Ľuboš. COVID-19 and CAR Tcells : a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.

Blood Adv. 2022. (Q1, IF:7,64)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Gangneux, F., R., Meroni, V., Dupont, D., Botterel, F., Garcia, J.M. A., Drgoňa, Ľ.: Toxoplasmosis in transplant recipiénts, Europe,2010-2014.

Emerging infectious diseases, 2018; 24 (8): 1497-1504.

CITATION: Ramanan, P., Scherger, S., Benamu, E., Bajrovic, V., Jackson, W. et al.: Transplant Infectious Disease, 2020; 22 (1): art. no.e13218.

Mikulska, M., Lanini, S., Gudiol, C., Drgoňa, Ľ., Ippolito, G. et al.: ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). Clinical Microbiology and Infection. 2018; 24 (Suppl. 2): S71-S82.

CITATION: Stocker, N. ,Labopin, M. , Boussen, I., Paccoud, O., Bonnin, A., Malard, F. et al.: BoneMarrowTransplantation, 2020; 55 (3): 586-594.

Kern, W. V., Marchetti, O., Drgoňa, Ľ., Akan, H., Aoun, M. et al.: Oral antibiotics for fever in low-risk neutropenic patients with cancer: A double-blind, randomized,multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy - EORTC Infectious Diseases Group Trial XV. J. Clin. Oncol., 2013; 31 (9): 1149-1156.

CITATION: Slavin, M.A., Thursky, K.A.: J. Clin. Oncol., 2013; 31 (9): 1128-1129. SCI ; SCOPUS

Mego, M., Chovanec, J., Vochyanová - Andrezalová, I., Konkolovský, P. Mikulová, M. ... Drgoňa, Ľ. et al.: Prevention of irinotecan induceddiarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine. 2015; 23 (3): 356-362.

CITATION: Panebianco, C., Latiano, T., Pazienza,V.: Frontiers in Oncology, 2020; 10: art. no. 679 - SCI ; SCOPUS

Drgoňa, Ľ., Gudiol, C., Lanini, S., Salzberger, B., Ippolito, G. et al.: ESCMID Study Group for Infections in Compromised Hosts(ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4). Clinical Microbiology and Infection. 2018; 24 (Suppl. 2): S83-S94.

CITATION: Godara, A., Palladini, G.: Hematology/Oncology Clinics of North America, 2020; 34 (6): 1145-1159 - SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

Monitoring of ibrutinib effectivity applied in B-cell type malignancies depending on

inflammatory status. Vega 1/0057/19

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position	VII.b - Name of the institution, board	VII.c - Duration
Head, Scientific Board	National Cancer Institute	2018 - ongoing
member, Collegium of Dean	Comenius University, Faculty of Medicine	2015 - ongoing

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

member Editorial Board „Onkologia“ / 2010 - ongoing/, "Via Practica" /2008- 2017/, "Transfuze a Hematologie dnes" /2019 - ongoing/, "Klinická Onkologie" /2019 - ongoing/
member of Executive Comittee, European Organisation for Research and Treatment of Cancer (Infectious Diseases Group) - member (executive committee member 2004-2008)

• Immunocompromised Host Society - member (2000 - ongoing)

• European Conference on Infections in Leukemia (ECIL) - member (2007 - ongoing)

• European Hematology Association (Infectious Diseases Group) - member (2018 - ongoing)

• European Society of Clinical Microbiology and Infectious Diseases 2010 - ongoing; (member of executive committee, secretary - ESGICH 2015-2017)

• Slovak Lymphoma Group (chair) 2016 - ongoing

• Slovak Medical Society - member 1995 - ongoing

• Slovak Society of Oncology member 1997- ongoing

• Slovak Society of Infectious Diseases member 1997 - ongoing

• Czech Leukemia Study Group for Life – CELL, member 2008- ongoing

• European Confederation of Clinical Mycology, fellow 2018 - ongoing

Date of last update

2025-05-26

Name and surname:	doc. MUDr. Ľuboš Drgoňa, CSc.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava